Cargando…
Reflection of treatment proficiency of hydroxyurea treated β-thalassemia serum samples through nuclear magnetic resonance based metabonomics
β-Thalassemia is a widespread autosomal recessive blood disorder found in most parts of the world. Fetal hemoglobin (HbF), a form of hemoglobin is found in infants, replaced by adult hemoglobin (HbA) after birth. Hydroxyurea (HU) is one of the most effective HbF inducer used for the treatment of ane...
Autores principales: | Khalid, Ayesha, Siddiqui, Amna Jabbar, Ansari, Saqib Hussain, Musharraf, Syed Ghulam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376050/ https://www.ncbi.nlm.nih.gov/pubmed/30765825 http://dx.doi.org/10.1038/s41598-019-38823-0 |
Ejemplares similares
-
Hydroxyurea Treated β-Thalassemia Children Demonstrate a Shift in Metabolism Towards Healthy Pattern
por: Iqbal, Ayesha, et al.
Publicado: (2018) -
Serum metabonomics of acute leukemia using nuclear magnetic resonance spectroscopy
por: Musharraf, Syed Ghulam, et al.
Publicado: (2016) -
β-Thalassemia Patients Revealed a Significant Change of Untargeted Metabolites in Comparison to Healthy Individuals
por: Musharraf, Syed Ghulam, et al.
Publicado: (2017) -
Evaluation of the combination therapy of hydroxyurea and thalidomide in β-thalassemia
por: Ansari, Saqib H., et al.
Publicado: (2022) -
Alteration of Serum Free Fatty Acids are Indicators for Progression of Pre-leukaemia Diseases to Leukaemia
por: Khalid, Ayesha, et al.
Publicado: (2018)